Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
The role of free fatty acids in idiopathic pulmonary fibrosis. 4635

Member's Comments

No comment yet.

Related content which might interest you: Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006 Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth Source: Eur Respir J 2015; 46: 1033-1045 Year: 2015 Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 An application of omega-3 polyunsaturated fatty acids in treatment of COPD patients with pulmonary hypertension and chronic cor pulmonale Source: Eur Respir J 2001; 18: Suppl. 33, 251s Year: 2001 Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 1024-1029 Year: 2008 Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 Hyaluronic acid is significantly increased in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 604s Year: 2006 Effectiveness of omega-3 polyunsaturated fatty acids in combination with acetylsalicylic acid in patients with COPD, complicated by cor pulmonale and the syndrome of blood hypercoagulation Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis Source: Eur Respir J 2007; 29: 958-964 Year: 2007 Is the unbalance between arachidonic acid and docosahexaenoic acid a reversible condition in adults With cystic fibrosis? Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Aging decreases pulmonary fibrosis reversibility via remodeling fatty acid metabolism of fibroblasts modulated by PRDM16 Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Omega-3 polyunsaturated fatty acids in correction of hemostasis system in patients with cor pulmonale Source: Eur Respir J 2002; 20: Suppl. 38, 100s Year: 2002 Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Essential phospholipids in pulmonary sarcoidosis Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008 Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016 Year: 2017 A first step against idiopathic pulmonary fibrosis Source: Eur Respir Rev 2011; 20: 130-131 Year: 2011